- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06868498
Train and EMPOWER A Community Health Workforce to Achieve Equity and Reduce Disparities in Mental Health (TEACH)
The investigators suggest a multi-step approach to improve access to mental health care for minority groups. The plan focuses on three goals: increasing diversity in the mental health workforce, bringing more expertise into the community, and strengthening the community's ability to address the factors that impact mental health.
To do this, the TEACH study team will work with students from underrepresented racial and ethnic groups at a minority-serving school. Students will be provided the opportunity to obtain their CHW Certification while receiving course credit for their degree. Students will then be eligible to participate in an internship to utilize their skills. The TEACH study team will help these students with their training, supervision, and ongoing support. These students will then be able to work with their communities to tackle common mental health issues and the social factors that contribute to those problems.
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Texas
-
Dallas, Texas, United States, 75204
- Baylor Scott and White Research Institute
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Must be enrolled as a UTA undergraduate student with unmet internship hours
- Must be aged 18 and over
- Must be able to provide informed consent.
- Must have successful completion of the UTA CHW/EMPOWER course (Phase 2) and/or State of Texas CHW certification (for non-EMPOWER-trained CHWs) at the start of internship
Exclusion Criteria:
- Under 18 years
- Not enrolled as an undergraduate student at UTA
- Unable to provide informed consent
- Non-successful completion of EMPOWER course and/or State of Texas CHW certification at the start of internship
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: EMPOWER-trained CHWs
Undergraduate students at the University of Texas at Arlington will engage in a semester-long course for training of students as CHWs with additional EMPOWER training for delivering a brief trans-diagnostic psychosocial intervention.
CHW certified students will then engage in an internship at Baylor Scott and White Health.
|
Students will participate in a special topics course resulting in a CHW certification with the state of Texas.
The course will focus on behavioral activation interventions.
Undergraduate Bachelor of Social Work (BSWs) students will then be deployed to the health system as certified CHWs with mental health training to provide a sufficient level of care for many, and an entry point to clinical care for those who have needs that are currently unaddressed.
|
|
No Intervention: Non-EMPOWER-trained interns
Intern health workers who have not undergone the EMPOWER training curriculum will engage in an internship at Baylor Scott and White Health.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Job Placement
Time Frame: 12 months after the intervention has ended
|
Data collected regarding career placement and/or further educational pursuits (i.e.
MSW)
|
12 months after the intervention has ended
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Post-traumatic Stress Disorder
Time Frame: Baseline, an average of 5 months after the start of the intervention, and immediately after the intervention, an average of 10 months
|
Diagnostic and Statistical Manual 5 PTSD Checklist - Scores range from 0-80 where higher scores indicate more severe PTSD symptoms
|
Baseline, an average of 5 months after the start of the intervention, and immediately after the intervention, an average of 10 months
|
|
Primary Care Visits
Time Frame: Immediately after the intervention, an average of 10 months
|
Healthcare Utilization - Number of primary care visits
|
Immediately after the intervention, an average of 10 months
|
|
Anxiety
Time Frame: Baseline, an average of 5 months after the start of the intervention, and immediately after the intervention, an average of 10 months
|
Generalized Anxiety Disorder 7 - Scores range from 0-21, where higher scores indicate more severe anxiety
|
Baseline, an average of 5 months after the start of the intervention, and immediately after the intervention, an average of 10 months
|
|
Behavioral Health Visits
Time Frame: Immediately after the intervention, an average of 10 months
|
Number of Behavioral Health Visits
|
Immediately after the intervention, an average of 10 months
|
|
Quality of Behavioral Health Visits
Time Frame: Immediately after the intervention, an average of 10 months
|
Description of the quality of any behavioral health visits
|
Immediately after the intervention, an average of 10 months
|
|
Acute Hospital Stays
Time Frame: Immediately after the intervention, an average of 10 months
|
Number of acute hospitalizations
|
Immediately after the intervention, an average of 10 months
|
|
Emergency Department Stays
Time Frame: Immediately after the intervention, an average of 10 months
|
Number of emergency department visits
|
Immediately after the intervention, an average of 10 months
|
|
Depression
Time Frame: Baseline, an average of 5 months after the start of the intervention, and immediately after the intervention, an average of 10 months
|
Patient Health Questionnaire 9 - Scores range from 0-27.
Higher scores indicates that major depressive disorder is likely.
|
Baseline, an average of 5 months after the start of the intervention, and immediately after the intervention, an average of 10 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Katherine Sanchez, PhD, LCSW, Baylor Scott and White Health
- Principal Investigator: Ann Marie Warren, PhD, ABPP-RP, Baylor Scott and White Health
Publications and helpful links
General Publications
- Naslund JA, Tugnawat D, Anand A, Cooper Z, Dimidjian S, Fairburn CG, Hollon SD, Joshi U, Khan A, Lu C, Mitchell LM, Muke S, Nadkarni A, Ramaswamy R, Restivo JL, Shrivastava R, Singh A, Singla DR, Spiegelman D, Bhan A, Patel V. Digital training for non-specialist health workers to deliver a brief psychological treatment for depression in India: Protocol for a three-arm randomized controlled trial. Contemp Clin Trials. 2021 Mar;102:106267. doi: 10.1016/j.cct.2021.106267. Epub 2021 Jan 6.
- Miller B, Burgos A. Enhancing the Capacity of the Mental Health and Addiction Workforce: A Framework. 2021. www.scattergoodfoundation.org
- Ma A, Sanchez A, Ma M. The Impact of Patient-Provider Race/Ethnicity Concordance on Provider Visits: Updated Evidence from the Medical Expenditure Panel Survey. J Racial Ethn Health Disparities. 2019 Oct;6(5):1011-1020. doi: 10.1007/s40615-019-00602-y. Epub 2019 Jun 24.
- Chao PJ, Steffen JJ, Heiby EM. The effects of working alliance and client-clinician ethnic match on recovery status. Community Ment Health J. 2012 Feb;48(1):91-7. doi: 10.1007/s10597-011-9423-8. Epub 2011 Jun 17.
- Hoge MA, Stuart GW, Morris J, Flaherty MT, Paris M Jr, Goplerud E. Mental health and addiction workforce development: federal leadership is needed to address the growing crisis. Health Aff (Millwood). 2013 Nov;32(11):2005-12. doi: 10.1377/hlthaff.2013.0541.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2024-0042.3
- 1U01MD019540-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.